Ireland
--:--IST
Latest
Clinical Trials in Canada / NCT05332301
Recruiting Not applicable

Sex Differences in Metabolism Following a High-fat Meal

NCT05332301 · tracked via the Priya Life Science Canada tracker
Sponsor
Kirsten Bell
Phase
Not applicable
Started
2022-10-04
Last updated
2025-08-19

Condition(s) studied

Healthy Nutrition

Investigational drug(s) / intervention(s)

High-fat test meal

High-fat test meal: Ingestion of a mixed macronutrient breakfast meal providing 846 kcal, of which 58% is fat, 29% is carbohydrate and 13% is protein.

Study summary

Long-term consumption (i.e., several weeks to months) of a diet that is high in fat (\>35% daily calories from fat) is associated with the development of insulin resistance, a condition that can lead to a diagnosis of type 2 diabetes. Women tend to be better protected against the development of high-fat diet-induced insulin resistance compared with men, but it is not fully understand why this sex difference exists. It is possible that women metabolize high-fat meals differently than men, which might explain why they are less likely to develop type 2 diabetes over the course of their lifetime. However, no one has ever compared the metabolic response to a high-fat meal between men and women in the hours immediately after ingestion.

During this study, the investigators will administer a single high-fat "fast-food" style breakfast meal (846 kcal, of which 58% is fat) to 24 health young adults (n=12 men, n=12 women) 18-35 years old. Their objective is to determine whether there are differences in the way men and women metabolize high-fat meals, such as this one. The research team will take regular blood samples after participants ingest this meal to measure features of glucose metabolism (e.g., blood glucose and insulin) as well as resting oxygen uptake (VO2) measurements to examine how much of this meal is burned for energy in the hours immediately after ingestion.

Eligibility

Sex
ALL
Min age
18 Years
Max age
35 Years
Healthy volunteers
Accepted
Inclusion Criteria: * BMI between 18.5 and 30.0 kg/m2 * Weight stable for the past 6 months (± 2kg) * Exercise at or below the Canadian Physical Activity Guidelinesa * Fasting blood glucose \<6.0 mM * Resting blood pressure \<140/90 mmHg * No hormone-altering contraceptive use (e.g., pill, patch, ring, injection) Exclusion Criteria: * Smoking * Diabetes, cancer, or other metabolic disorders * Cardiac or gastrointestinal problems * Infectious disease * Barium swallow or nuclear medicine scan in the previous 3 weeks * Pregnant or breastfeeding * Diagnosis of polycystic ovary syndrome * Follow a vegan or vegetarian diet * Not fully vaccinated against COVID19

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
McMaster University Hamilton Ontario Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05332301 on ClinicalTrials.gov ↗ ← All trials in Canada